Ex-con Sam Wak­sal's start­up prices IPO, join­ing pa­rade of biotechs with Nas­daq news

Biotechs are com­ing out of the wood­work this morn­ing to set terms for their IPOs. So far, we’ve tracked five com­pa­nies rais­ing rough­ly $486 mil­lion com­bined, in­clud­ing an IPO from ex-con Sam Wak­sal’s Kad­mon spin­off MeiraGTx $MGTX.

MeriaGTx — $75 mil­lion

The com­pa­ny’s founder, Wak­sal, is a biotech ex­ec once sen­tenced to prison for his in­sid­er trad­ing con­vic­tion in­volv­ing Martha Stew­art. He was al­so the founder of Kad­mon, a com­pa­ny he had to bail from be­fore it could file its own IPO back in 2016. And now his brain­child — un­der the di­rec­tion of for­mer Kad­mon com­mer­cial chief Alexan­dria Forbes — has filed to raise $75 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER